title: Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma.
authors: Division of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona.
authors: Tania
authors: T
authors: Jain
authors: Department of Biostatistics, Mayo Clinic, Scottsdale, Arizona.
authors: Amylou C
authors: AC
authors: Dueck
authors: Department of Biostatistics, Mayo Clinic, Scottsdale, Arizona.
authors: Heidi E
authors: HE
authors: Kosiorek
authors: Department of Biostatistics, Mayo Clinic, Scottsdale, Arizona.
authors: Brenda F
authors: BF
authors: Ginos
authors: Division of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona.
authors: Angela
authors: A
authors: Mayo
authors: Division of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona.
authors: Craig B
authors: CB
authors: Reeder
authors: Division of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona.
authors: Marta
authors: M
authors: Chesi
authors: Division of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona.
authors: Joseph
authors: J
authors: Mikhael
authors: Division of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona.
authors: A
authors: A
authors: Keith Stewart
authors: Division of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona.
authors: P
authors: P
authors: Leif Bergsagel
authors: Division of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona.
authors: Rafael
authors: R
authors: Fonseca
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000418:Albumins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology; D017239:Paclitaxel / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D012008:Recurrence
chemical_list: C520255:130-nm albumin-bound paclitaxel; D000418:Albumins; D017239:Paclitaxel